In the early 1990s, faced Merck a number of challenges because of the significant changes in the competitive environment and regulatory environment (eg growth of the power of the pharmaceutical buyers such as managed care organizations led to price pressure and President Clinton’s review of the entire U.S. health industry ). The case describes the company under its previous CEO, and especially under Ray Gilmartin, the new CEO. Discusses the strategic, organizational, cultural and management challenges that Merck f … Read more »

In the early 1990s, faced Merck a number of challenges because of the significant changes in the competitive environment and regulatory environment (eg growth of the power of the pharmaceutical buyers such as managed care organizations led to price pressure and President Clinton’s review of the entire U.S. health industry ). The case describes the company under its previous CEO, and especially under Ray Gilmartin, the new CEO. Discusses the strategic, organizational, cultural and management challenges that confronted Merck and Gilmartin was directed modification program from 1994 to 1998 to help Merck to address these problems.
«Hide

from
Michael Beer,
Perry L. Fagan
Source: Harvard Business School
20 pages.
Release Date: 29 March 1999. Prod #: 499054-PDF-ENG
Merck & Co., Inc.: Corporate Strategy, organization and culture (A) HBR case solution